ivWatch has partnered with leaders in the medical device and health care space to allow institutions to reduce patient harm and improve patient safety by providing continuous monitoring technology for the early detection of IV infiltrations and extravasations.
As the market leader for continuous IV infiltration and extravasation detection technology, ivWatch and Terumo Corporation, one of the world’s leading medical device manufacturers and distributors, have agreed that Terumo will be the exclusive distributor of the ivWatch Model 400 and the ivWatch OEM board in Japan, and is a global licensing partner for Terumo products containing the ivWatch OEM board.**
Vizient-served members can contact their Vizient account manager or access additional information on the ivWatch Model 400 through the Vizient member portal.
Premier members can contact their Premier account manager or access additional information on the ivWatch Model 400 through the Premier member portal. Please reference contract number PP-NS-1123.